<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Coagulation,Coagulation,Blood physiology,AIDS,Acenocoumarol,Adenosine diphosphate,Adenylyl cyclase,Alexander Schmidt (physiologist),Alpha 2-antiplasmin,Alpha 2-macroglobulin,Alpha granules" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Coagulation&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Coagulation&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Coagulation - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Coagulation";
		var wgTitle = "Coagulation";
		var wgAction = "view";
		var wgArticleId = "212193";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281786867;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Coagulation skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Coagulation</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<div class="dablink">This article is about the clotting of blood.  For other uses, see <a href="/wiki/Coagulation_(disambiguation)" title="Coagulation (disambiguation)">Coagulation (disambiguation)</a>.</div>
<p><b>Coagulation</b> is a complex process by which <a href="/wiki/Blood" title="Blood">blood</a> forms <a href="/wiki/Clot" title="Clot" class="mw-redirect">clots</a>. It is an important part of <a href="/wiki/Hemostasis" title="Hemostasis">hemostasis</a> (the cessation of blood loss from a damaged vessel), wherein a damaged <a href="/wiki/Blood_vessel" title="Blood vessel">blood vessel</a> wall is covered by a <a href="/wiki/Platelet" title="Platelet">platelet</a> and <a href="/wiki/Fibrin" title="Fibrin">fibrin</a>-containing clot to stop <a href="/wiki/Hemorrhage" title="Hemorrhage" class="mw-redirect">bleeding</a> and begin repair of the damaged vessel. Disorders of coagulation can lead to an increased risk of bleeding (<a href="/wiki/Hemorrhage" title="Hemorrhage" class="mw-redirect">hemorrhage</a>) or clotting (<a href="/wiki/Thrombosis" title="Thrombosis">thrombosis</a>).</p>
<p>Coagulation is highly <a href="/wiki/Conservation_(genetics)" title="Conservation (genetics)">conserved</a> throughout biology; in all <a href="/wiki/Mammal" title="Mammal">mammals</a>, coagulation involves both a cellular (platelet) and a <a href="/wiki/Protein" title="Protein">protein</a> (coagulation factor) component. The system in humans has been the most extensively researched and, therefore, the best-understood.</p>
<p>Coagulation begins almost instantly after an injury to the blood vessel has damaged the <a href="/wiki/Endothelium" title="Endothelium">endothelium</a> (lining of the vessel). <a href="/wiki/Platelet" title="Platelet">Platelets</a> immediately form a plug at the site of injury; this is called <i>primary hemostasis</i>. <i>Secondary hemostasis</i> occurs simultaneously: Proteins in the <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a>, called <i>coagulation factors</i> or <i>clotting factors</i>, respond in a complex cascade to form <a href="/wiki/Fibrin" title="Fibrin">fibrin</a> strands, which strengthen the platelet plug.<sup id="cite_ref-Furie_0-0" class="reference"><a href="#cite_note-Furie-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Physiology"><span class="tocnumber">1</span> <span class="toctext">Physiology</span></a>
<ul>
<li class="toclevel-2"><a href="#Platelet_activation"><span class="tocnumber">1.1</span> <span class="toctext">Platelet activation</span></a></li>
<li class="toclevel-2"><a href="#The_coagulation_cascade"><span class="tocnumber">1.2</span> <span class="toctext">The coagulation cascade</span></a>
<ul>
<li class="toclevel-3"><a href="#Tissue_factor_pathway_.28extrinsic.29"><span class="tocnumber">1.2.1</span> <span class="toctext">Tissue factor pathway (extrinsic)</span></a></li>
<li class="toclevel-3"><a href="#Contact_activation_pathway_.28intrinsic.29"><span class="tocnumber">1.2.2</span> <span class="toctext">Contact activation pathway (intrinsic)</span></a></li>
<li class="toclevel-3"><a href="#Final_common_pathway"><span class="tocnumber">1.2.3</span> <span class="toctext">Final common pathway</span></a></li>
</ul>
</li>
<li class="toclevel-2"><a href="#Cofactors"><span class="tocnumber">1.3</span> <span class="toctext">Cofactors</span></a></li>
<li class="toclevel-2"><a href="#Regulators"><span class="tocnumber">1.4</span> <span class="toctext">Regulators</span></a></li>
<li class="toclevel-2"><a href="#Fibrinolysis"><span class="tocnumber">1.5</span> <span class="toctext">Fibrinolysis</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Testing_of_coagulation"><span class="tocnumber">2</span> <span class="toctext">Testing of coagulation</span></a></li>
<li class="toclevel-1"><a href="#Role_in_disease"><span class="tocnumber">3</span> <span class="toctext">Role in disease</span></a>
<ul>
<li class="toclevel-2"><a href="#Platelet_disorders"><span class="tocnumber">3.1</span> <span class="toctext">Platelet disorders</span></a></li>
<li class="toclevel-2"><a href="#Disease_and_clinical_significance_of_thrombosis"><span class="tocnumber">3.2</span> <span class="toctext">Disease and clinical significance of thrombosis</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Pharmacology"><span class="tocnumber">4</span> <span class="toctext">Pharmacology</span></a>
<ul>
<li class="toclevel-2"><a href="#Procoagulants"><span class="tocnumber">4.1</span> <span class="toctext">Procoagulants</span></a></li>
<li class="toclevel-2"><a href="#Anticoagulants"><span class="tocnumber">4.2</span> <span class="toctext">Anticoagulants</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Coagulation_factors"><span class="tocnumber">5</span> <span class="toctext">Coagulation factors</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">6</span> <span class="toctext">History</span></a>
<ul>
<li class="toclevel-2"><a href="#Initial_discoveries"><span class="tocnumber">6.1</span> <span class="toctext">Initial discoveries</span></a></li>
<li class="toclevel-2"><a href="#Coagulation_factors_2"><span class="tocnumber">6.2</span> <span class="toctext">Coagulation factors</span></a></li>
<li class="toclevel-2"><a href="#Nomenclature"><span class="tocnumber">6.3</span> <span class="toctext">Nomenclature</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Other_species"><span class="tocnumber">7</span> <span class="toctext">Other species</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a>
<ul>
<li class="toclevel-2"><a href="#3D_structures"><span class="tocnumber">9.1</span> <span class="toctext">3D structures</span></a></li>
</ul>
</li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Physiology" id="Physiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=1" title="Edit section: Physiology">edit</a>]</span> <span class="mw-headline">Physiology</span></h2>
<p><a name="Platelet_activation" id="Platelet_activation"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=2" title="Edit section: Platelet activation">edit</a>]</span> <span class="mw-headline">Platelet activation</span></h3>
<p>Damage to blood vessel walls exposes subendothelium proteins, most notably <a href="/wiki/Collagen" title="Collagen">collagen</a>, present under the <a href="/wiki/Endothelium" title="Endothelium">endothelium</a>. Circulating platelets bind collagen with surface collagen-specific <a href="/wiki/Glycoprotein" title="Glycoprotein">glycoprotein</a> Ia/IIa receptors. The adhesion is strengthened further by the large, multimeric circulating proteins <a href="/wiki/Von_Willebrand_factor" title="Von Willebrand factor">von Willebrand factor</a> (vWF), which forms links between the platelets glycoprotein Ib/IX/V and the collagen fibrils. This adhesion activates the platelets.</p>
<p>Activated platelets release the contents of stored granules into the blood plasma. The granules include <a href="/wiki/Adenosine_diphosphate" title="Adenosine diphosphate">ADP</a>, <a href="/wiki/Serotonin" title="Serotonin">serotonin</a>, <a href="/wiki/Platelet-activating_factor" title="Platelet-activating factor">platelet-activating factor</a> (PAF), <a href="/wiki/Von_Willebrand_factor" title="Von Willebrand factor">vWF</a>, <a href="/wiki/Platelet_factor_4" title="Platelet factor 4">platelet factor 4</a>, and <a href="/wiki/Thromboxane_A2" title="Thromboxane A2">thromboxane A<sub>2</sub></a> (TXA<sub>2</sub>), which, in turn, activate additional platelets. The granules' contents activate a <a href="/wiki/G_protein-coupled_receptor" title="G protein-coupled receptor">G<sub>q</sub>-linked protein receptor</a> cascade, resulting in increased calcium concentration in the platelets' cytosol. The calcium activates <a href="/wiki/Protein_kinase_C" title="Protein kinase C">protein kinase C</a>, which, in turn, activates <a href="/wiki/Phospholipase_A2" title="Phospholipase A2">phospholipase A<sub>2</sub></a> (PLA<sub>2</sub>). PLA<sub>2</sub> then modifies the <a href="/wiki/Integrin" title="Integrin">integrin</a> membrane glycoprotein IIb/IIIa, increasing its affinity to bind fibrinogen. The activated platelets change shape from spherical to stellate, and the fibrinogen cross-links with glycoprotein IIb/IIIa aid in aggregation of adjacent platelets.</p>
<p><a name="The_coagulation_cascade" id="The_coagulation_cascade"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=3" title="Edit section: The coagulation cascade">edit</a>]</span> <span class="mw-headline">The coagulation cascade</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:402px;"><a href="/wiki/File:Coagulation_full.svg" class="image" title="The coagulation cascade."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Coagulation_full.svg/400px-Coagulation_full.svg.png" width="400" height="320" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Coagulation_full.svg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
The coagulation cascade.</div>
</div>
</div>
<p>The coagulation cascade of secondary hemostasis has two pathways, the <i>contact activation pathway</i> (formerly known as the intrinsic pathway), and the <i>tissue factor pathway</i> (formerly known as the extrinsic pathway), which lead to <i>fibrin</i> formation. It was previously thought that the coagulation cascade consisted of two pathways of equal importance joined to a common pathway. It is now known that the primary pathway for the initiation of blood coagulation is the <i>tissue factor</i> pathway. The pathways are a series of reactions, in which a <a href="/wiki/Zymogen" title="Zymogen">zymogen</a> (inactive enzyme precursor) of a <a href="/wiki/Serine_protease" title="Serine protease">serine protease</a> and its <a href="/wiki/Glycoprotein" title="Glycoprotein">glycoprotein</a> co-factor are activated to become active components that then catalyze the next reaction in the cascade, ultimately resulting in cross-linked fibrin. Coagulation factors are generally indicated by <a href="/wiki/Roman_numeral" title="Roman numeral" class="mw-redirect">Roman numerals</a>, with a lowercase <i>a</i> appended to indicate an active form.</p>
<p>The coagulation factors are generally <a href="/wiki/Serine_protease" title="Serine protease">serine proteases</a> (<a href="/wiki/Enzymes" title="Enzymes" class="mw-redirect">enzymes</a>). There are some exceptions. For example, FVIII and FV are glycoproteins, and Factor XIII is a <a href="/wiki/Transglutaminase" title="Transglutaminase">transglutaminase</a>. Serine proteases act by cleaving other proteins at specific sites. The coagulation factors circulate as inactive <a href="/wiki/Zymogens" title="Zymogens" class="mw-redirect">zymogens</a>. The coagulation cascade is classically divided into three pathways. The <i>tissue factor</i> and <i>contact activation</i> pathways both activate the "final common pathway" of factor X, thrombin and fibrin.</p>
<p><a name="Tissue_factor_pathway_.28extrinsic.29" id="Tissue_factor_pathway_.28extrinsic.29"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=4" title="Edit section: Tissue factor pathway (extrinsic)">edit</a>]</span> <span class="mw-headline">Tissue factor pathway (extrinsic)</span></h4>
<p>The main role of the tissue factor pathway is to generate a "thrombin burst," a process by which <a href="/wiki/Thrombin" title="Thrombin">thrombin</a>, the most important constituent of the coagulation cascade in terms of its feedback activation roles, is released instantaneously. FVIIa circulates in a higher amount than any other activated coagulation factor.</p>
<ul>
<li>Following damage to the blood vessel, FVII leaves the circulation and comes into contact with <a href="/wiki/Tissue_factor" title="Tissue factor">Tissue factor</a> (TF) expressed on Tissue Factor Baring Cells (stromal fibroblasts and leukocytes), forming a complex (TF-FVIIa) and in so doing, activating it.</li>
<li>TF-FVIIa activates FIX and FX.</li>
<li>FVII is itself activated by thrombin, FXIa, <a href="/wiki/Plasmin" title="Plasmin">plasmin</a>, FXII and FXa.</li>
<li>The activation of FXa by TF-FVIIa is almost immediately inhibited by <a href="/wiki/Tissue_factor_pathway_inhibitor" title="Tissue factor pathway inhibitor">tissue factor pathway inhibitor</a> (TFPI).</li>
<li>FXa and its co-factor FVa form the <a href="/wiki/Prothrombinase" title="Prothrombinase">prothrombinase</a> complex, which activates <a href="/wiki/Prothrombin" title="Prothrombin" class="mw-redirect">prothrombin</a> to thrombin.</li>
<li>Thrombin then activates other components of the coagulation cascade, including FV and FVIII (which activates FXI, which, in turn, activates FIX), and activates and releases FVIII from being bound to vWF.</li>
<li>FVIIIa is the co-factor of FIXa, and together they form the "<a href="/wiki/Tenase" title="Tenase">tenase</a>" complex, which activates FX; and so the cycle continues. ("Tenase" is a contraction of "ten" and the suffix "-ase" used for enzymes.)</li>
</ul>
<p><a name="Contact_activation_pathway_.28intrinsic.29" id="Contact_activation_pathway_.28intrinsic.29"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=5" title="Edit section: Contact activation pathway (intrinsic)">edit</a>]</span> <span class="mw-headline">Contact activation pathway (intrinsic)</span></h4>
<p>The contact activation pathway begins with formation of the primary complex on <a href="/wiki/Collagen" title="Collagen">collagen</a> by <a href="/wiki/High-molecular-weight_kininogen" title="High-molecular-weight kininogen">high-molecular-weight kininogen</a> (HMWK), <a href="/wiki/Prekallikrein" title="Prekallikrein">prekallikrein</a>, and FXII (Hageman factor). <a href="/wiki/Prekallikrein" title="Prekallikrein">Prekallikrein</a> is converted to <a href="/wiki/Kallikrein" title="Kallikrein">kallikrein</a> and FXII becomes FXIIa. FXIIa converts FXI into FXIa. Factor XIa activates FIX, which with its co-factor FVIIIa form the <a href="/wiki/Tenase" title="Tenase">tenase</a> complex, which activates FX to FXa. The minor role that the contact activation pathway has in initiating <a href="/wiki/Clot_formation" title="Clot formation" class="mw-redirect">clot formation</a> can be illustrated by the fact that patients with severe deficiencies of FXII, HMWK, and <a href="/wiki/Prekallikrein" title="Prekallikrein">prekallikrein</a> do not have a bleeding disorder.</p>
<p><a name="Final_common_pathway" id="Final_common_pathway"></a></p>
<h4><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=6" title="Edit section: Final common pathway">edit</a>]</span> <span class="mw-headline">Final common pathway</span></h4>
<p><i>Thrombin</i> has a large array of functions. Its primary role is the conversion of <a href="/wiki/Fibrinogen" title="Fibrinogen" class="mw-redirect">fibrinogen</a> to fibrin, the building block of a hemostatic plug. In addition, it activates Factors VIII and V and their inhibitor <a href="/wiki/Protein_C" title="Protein C">protein C</a> (in the presence of <a href="/wiki/Thrombomodulin" title="Thrombomodulin">thrombomodulin</a>), and it activates Factor XIII, which forms <a href="/wiki/Covalent_bond" title="Covalent bond">covalent bonds</a> that crosslink the fibrin polymers that form from activated monomers.</p>
<p>Following activation by the contact factor or tissue factor pathways, the coagulation cascade is maintained in a prothrombotic state by the continued activation of FVIII and FIX to form the <a href="/wiki/Tenase" title="Tenase">tenase</a> complex, until it is down-regulated by the anticoagulant pathways.</p>
<p><a name="Cofactors" id="Cofactors"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=7" title="Edit section: Cofactors">edit</a>]</span> <span class="mw-headline">Cofactors</span></h3>
<p>Various substances are required for the proper functioning of the coagulation cascade:</p>
<ul>
<li><a href="/wiki/Calcium" title="Calcium">Calcium</a> and <a href="/wiki/Phospholipid" title="Phospholipid">phospholipid</a> (a <a href="/wiki/Platelet" title="Platelet">platelet</a> membrane constituent) are required for the tenase and prothrombinase complexes to function. Calcium mediates the binding of the complexes via the terminal gamma-carboxy residues on FXa and FIXa to the phospholipid surfaces expressed by platelets, as well as procoagulant microparticles or <a href="/wiki/Microvesicles" title="Microvesicles">microvesicles</a> shed from them. Calcium is also required at other points in the coagulation cascade.</li>
<li><a href="/wiki/Vitamin_K" title="Vitamin K">Vitamin K</a> is an essential factor to a hepatic <a href="/wiki/Gamma-glutamyl_carboxylase" title="Gamma-glutamyl carboxylase">gamma-glutamyl carboxylase</a> that adds a <a href="/wiki/Carboxyl" title="Carboxyl" class="mw-redirect">carboxyl</a> group to <a href="/wiki/Glutamic_acid" title="Glutamic acid">glutamic acid</a> residues on factors II, VII, IX and X, as well as <a href="/wiki/Protein_S" title="Protein S">Protein S</a>, Protein C and <a href="/wiki/Protein_Z" title="Protein Z">Protein Z</a>. In adding the gamma-carboxyl group to glutamate residues on the immature clotting factors Vitamin K is itself oxidized. Another enzyme, <i><a href="/wiki/Vitamin_K_epoxide_reductase" title="Vitamin K epoxide reductase">Vitamin K epoxide reductase</a></i>, (VKORC) reduces vitamin K back to its active form. Vitamin K epoxide reductase is pharmacologically important as a target for anticoagulant drugs <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> and related <a href="/wiki/Coumarin" title="Coumarin">coumarins</a> such as <a href="/wiki/Acenocoumarol" title="Acenocoumarol">acenocoumarol</a>, <a href="/wiki/Phenprocoumon" title="Phenprocoumon">phenprocoumon</a>, and <a href="/wiki/Dicumarol" title="Dicumarol" class="mw-redirect">dicumarol</a>. These drugs create a deficiency of reduced vitamin K by blocking VKORC, thereby inhibiting maturation of clotting factors. Other deficiencies of vitamin K (e.g., in <a href="/wiki/Malabsorption" title="Malabsorption">malabsorption</a>), or disease (<a href="/wiki/Hepatocellular_carcinoma" title="Hepatocellular carcinoma">hepatocellular carcinoma</a>) impairs the function of the enzyme and leads to the formation of PIVKAs (proteins formed in vitamin K absence); this causes partial or non-gamma carboxylation, and affects the coagulation factors' ability to bind to expressed phospholipid.</li>
</ul>
<p><a name="Regulators" id="Regulators"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=8" title="Edit section: Regulators">edit</a>]</span> <span class="mw-headline">Regulators</span></h3>
<p>Five mechanisms keep platelet activation and the coagulation cascade in check. Abnormalities can lead to an increased tendency toward thrombosis:</p>
<ul>
<li><a href="/wiki/Protein_C" title="Protein C">Protein C</a> is a major physiological anticoagulant. It is a vitamin K-dependent serine protease enzyme that is activated by thrombin into activated protein C (APC). Protein C is activated in a sequence that starts with Protein C and thrombin binding to a cell surface protein <a href="/wiki/Thrombomodulin" title="Thrombomodulin">thrombomodulin</a>. Thrombomodulin binds these proteins in such a way that it activates Protein C. The activated form, along with protein S and a phospholipid as cofactors, degrades FVa and FVIIIa. Quantitative or qualitative deficiency of either may lead to <a href="/wiki/Thrombophilia" title="Thrombophilia">thrombophilia</a> (a tendency to develop thrombosis). Impaired action of Protein C (activated Protein C resistance), for example by <a href="/wiki/Factor_V_Leiden" title="Factor V Leiden">having the "Leiden" variant of Factor V</a> or high levels of FVIII also may lead to a thrombotic tendency.</li>
<li><a href="/wiki/Antithrombin" title="Antithrombin">Antithrombin</a> is a <a href="/wiki/Serine_protease_inhibitor" title="Serine protease inhibitor" class="mw-redirect">serine protease inhibitor</a> (<a href="/wiki/Serpin" title="Serpin">serpin</a>) that degrades the serine proteases: thrombin, FIXa, FXa, FXIa, and FXIIa. It is constantly active, but its adhesion to these factors is increased by the presence of <a href="/wiki/Heparan_sulfate" title="Heparan sulfate">heparan sulfate</a> (a <a href="/wiki/Glycosaminoglycan" title="Glycosaminoglycan">glycosaminoglycan</a>) or the administration of <a href="/wiki/Heparin" title="Heparin">heparins</a> (different heparinoids increase affinity to FXa, thrombin, or both). Quantitative or qualitative deficiency of antithrombin (inborn or acquired, e.g., in <a href="/wiki/Proteinuria" title="Proteinuria">proteinuria</a>) leads to thrombophilia.</li>
<li><a href="/wiki/Tissue_factor_pathway_inhibitor" title="Tissue factor pathway inhibitor">Tissue factor pathway inhibitor</a> (TFPI) limits the action of tissue factor (TF). It also inhibits excessive TF-mediated activation of FIX and FX.</li>
<li><a href="/wiki/Plasmin" title="Plasmin">Plasmin</a> is generated by proteolytic cleavage of plasminogen, a plasma protein synthesized in the liver. This cleavage is catalyzed by <a href="/wiki/Tissue_plasminogen_activator" title="Tissue plasminogen activator">tissue plasminogen activator</a> (t-PA), which is synthesized and secreted by endothelium. Plasmin proteolytically cleaves fibrin into fibrin degradation products that inhibit excessive fibrin formation.</li>
<li><a href="/wiki/Prostacyclin" title="Prostacyclin">Prostacyclin</a> (PGI<sub>2</sub>) is released by endothelium and activates platelet G<sub>s</sub> protein-linked receptors. This, in turn, activates <a href="/wiki/Adenylyl_cyclase" title="Adenylyl cyclase" class="mw-redirect">adenylyl cyclase</a>, which synthesizes cAMP. cAMP inhibits platelet activation by counteracting the actions that result from increased cytosolic levels of calcium and, by doing so, inhibits the release of granules that would lead to activation of additional platelets and the coagulation cascade.</li>
</ul>
<p><a name="Fibrinolysis" id="Fibrinolysis"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=9" title="Edit section: Fibrinolysis">edit</a>]</span> <span class="mw-headline">Fibrinolysis</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Fibrinolysis" title="Fibrinolysis">Fibrinolysis</a></div>
<p>Eventually, all blood clots are reorganised and resorbed by a process termed <i><a href="/wiki/Fibrinolysis" title="Fibrinolysis">fibrinolysis</a></i>. The main enzyme responsible for this process (<a href="/wiki/Plasmin" title="Plasmin">plasmin</a>) is regulated by various activators and inhibitors.</p>
<p><a name="Testing_of_coagulation" id="Testing_of_coagulation"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=10" title="Edit section: Testing of coagulation">edit</a>]</span> <span class="mw-headline">Testing of coagulation</span></h2>
<p>Numerous tests are used to assess the function of the coagulation system:</p>
<ul>
<li>Common: <a href="/wiki/Partial_thromboplastin_time" title="Partial thromboplastin time">aPTT</a>, <a href="/wiki/Prothrombin_time" title="Prothrombin time">PT</a> (also used to determine <a href="/wiki/International_normalized_ratio" title="International normalized ratio" class="mw-redirect">INR</a>), <a href="/wiki/Fibrinogen" title="Fibrinogen" class="mw-redirect">fibrinogen</a> testing (often by the <a href="/w/index.php?title=Clauss_method&amp;action=edit&amp;redlink=1" class="new" title="Clauss method (page does not exist)">Clauss method</a>), <a href="/wiki/Platelet" title="Platelet">platelet</a> count, platelet function testing (often by <a href="/wiki/PFA-100" title="PFA-100">PFA-100</a>).</li>
<li>Other: <a href="/wiki/Thrombin_clotting_time" title="Thrombin clotting time" class="mw-redirect">TCT</a>, <a href="/wiki/Bleeding_time" title="Bleeding time">bleeding time</a>, <a href="/wiki/Mixing_test" title="Mixing test">mixing test</a> (whether an abnormality corrects if the patient's plasma is mixed with normal plasma), coagulation factor assays, <a href="/wiki/Antiphospholipid_antibody" title="Antiphospholipid antibody" class="mw-redirect">antiphosholipid antibodies</a>, <a href="/wiki/D-dimer" title="D-dimer">D-dimer</a>, genetic tests (eg. <a href="/wiki/Factor_V_Leiden" title="Factor V Leiden">factor V Leiden</a>, <a href="/wiki/Prothrombin" title="Prothrombin" class="mw-redirect">prothrombin</a> mutation G20210A), <a href="/wiki/Dilute_Russell%27s_viper_venom_time" title="Dilute Russell's viper venom time">dilute Russell's viper venom time</a> (dRVVT), miscellaneous platelet function tests, <a href="/wiki/Thromboelastography" title="Thromboelastography">thromboelastography</a> (TEG or ROTEM), <a href="/wiki/Euglobulin_lysis_time" title="Euglobulin lysis time">euglobulin lysis time</a> (ELT), .</li>
</ul>
<p>The contact factor pathway is initiated by activation of the "contact factors" of plasma, and can be measured by the <a href="/wiki/Partial_thromboplastin_time" title="Partial thromboplastin time">activated partial thromboplastin</a> time (aPTT) test.</p>
<p>The tissue factor pathway is initiated by release of <a href="/wiki/Tissue_factor" title="Tissue factor">tissue factor</a> (a specific cellular lipoprotein), and can be measured by the <a href="/wiki/Prothrombin_time" title="Prothrombin time">prothrombin time</a> (PT) test. PT results are often reported as ratio (<a href="/wiki/International_normalized_ratio" title="International normalized ratio" class="mw-redirect">INR</a> value) to monitor dosing of oral anticoagulants such as <a href="/wiki/Warfarin" title="Warfarin">warfarin</a>.</p>
<p>The quantitative and qualitative screening of fibrinogen is measured by the <a href="/wiki/Thrombin_clotting_time" title="Thrombin clotting time" class="mw-redirect">thrombin clotting time</a> (TCT). Measurement of the exact amount of fibrinogen present in the blood is generally done using the <a href="/w/index.php?title=Clauss_method&amp;action=edit&amp;redlink=1" class="new" title="Clauss method (page does not exist)">Clauss method</a> for fibrinogen testing. Many analysers are capable of measuring a "derived fibrinogen" level from the graph of the Prothrombin time clot.</p>
<p>If a coagulation factor is part of the contact or tissue factor pathway, a deficiency of that factor will affect only one of the tests: Thus <a href="/wiki/Hemophilia_A" title="Hemophilia A" class="mw-redirect">hemophilia A</a>, a deficiency of factor VIII, which is part of the contact factor pathway, results in an abnormally prolonged aPTT test but a normal PT test. The exceptions are prothrombin, fibrinogen, and some variants of FX that can be detected only by either aPTT or PT. If an abnormal PT or aPTT is present, additional testing will occur to determine which (if any) factor is present as aberrant concentrations.</p>
<p>Deficiencies of fibrinogen (quantitative or qualitative) will affect all screening tests.</p>
<p><a name="Role_in_disease" id="Role_in_disease"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=11" title="Edit section: Role in disease">edit</a>]</span> <span class="mw-headline">Role in disease</span></h2>
<p>Problems with coagulation may dispose to hemorrhage, thrombosis, and occasionally both, depending on the nature of the pathology.</p>
<p><a name="Platelet_disorders" id="Platelet_disorders"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=12" title="Edit section: Platelet disorders">edit</a>]</span> <span class="mw-headline">Platelet disorders</span></h3>
<p>Platelet conditions may be inborn or acquired. Some inborn platelet pathologies are <a href="/wiki/Glanzmann%27s_thrombasthenia" title="Glanzmann's thrombasthenia">Glanzmann's thrombasthenia</a>, <a href="/wiki/Bernard-Soulier_syndrome" title="Bernard-Soulier syndrome">Bernard-Soulier syndrome</a> (abnormal glycoprotein Ib-IX-V complex), <a href="/wiki/Gray_platelet_syndrome" title="Gray platelet syndrome">gray platelet syndrome</a> (deficient <a href="/wiki/Alpha_granules" title="Alpha granules" class="mw-redirect">alpha granules</a>), and <a href="/wiki/Delta_storage_pool_deficiency" title="Delta storage pool deficiency" class="mw-redirect">delta storage pool deficiency</a> (deficient <a href="/wiki/Dense_granules" title="Dense granules" class="mw-redirect">dense granules</a>). Most are rare conditions. Most inborn platelet pathologies predispose to hemorrhage. <a href="/wiki/Von_Willebrand_disease" title="Von Willebrand disease">Von Willebrand disease</a> is due to deficiency or abnormal function of <a href="/wiki/Von_Willebrand_factor" title="Von Willebrand factor">von Willebrand factor</a>, and leads to a similar bleeding pattern; its milder forms are relatively common.</p>
<p>Decreased platelet numbers may be due to various causes, including insufficient production (e.g., in <a href="/wiki/Myelodysplastic_syndrome" title="Myelodysplastic syndrome">myelodysplastic syndrome</a> or other bone marrow disorders), destruction by the immune system (<a href="/wiki/Immune_thrombocytopenic_purpura" title="Immune thrombocytopenic purpura" class="mw-redirect">immune thrombocytopenic purpura</a>/ITP), and consumption due to various causes (<a href="/wiki/Thrombotic_thrombocytopenic_purpura" title="Thrombotic thrombocytopenic purpura">thrombotic thrombocytopenic purpura</a>/TTP, <a href="/wiki/Hemolytic-uremic_syndrome" title="Hemolytic-uremic syndrome">hemolytic-uremic syndrome</a>/HUS, <a href="/wiki/Paroxysmal_nocturnal_hemoglobinuria" title="Paroxysmal nocturnal hemoglobinuria">paroxysmal nocturnal hemoglobinuria</a>/PNH, <a href="/wiki/Disseminated_intravascular_coagulation" title="Disseminated intravascular coagulation">disseminated intravascular coagulation</a>/DIC, <a href="/wiki/Heparin-induced_thrombocytopenia" title="Heparin-induced thrombocytopenia">heparin-induced thrombocytopenia</a>/HIT). Most consumptive conditions lead to platelet activation, and some are associated with thrombosis.</p>
<p><a name="Disease_and_clinical_significance_of_thrombosis" id="Disease_and_clinical_significance_of_thrombosis"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=13" title="Edit section: Disease and clinical significance of thrombosis">edit</a>]</span> <span class="mw-headline">Disease and clinical significance of thrombosis</span></h3>
<p>The best-known coagulation factor disorders are the <a href="/wiki/Hemophilia" title="Hemophilia" class="mw-redirect">hemophilias</a>. The three main forms are <a href="/wiki/Hemophilia_A" title="Hemophilia A" class="mw-redirect">hemophilia A</a> (factor VIII deficiency), <a href="/wiki/Hemophilia_B" title="Hemophilia B" class="mw-redirect">hemophilia B</a> (factor IX deficiency or "Christmas disease") and <a href="/wiki/Hemophilia_C" title="Hemophilia C" class="mw-redirect">hemophilia C</a> (factor XI deficiency, mild bleeding tendency). Hemophilia A and B are X-linked recessive disorders, whereas Hemophilia C is much more rare autosomal recessive disorder most commonly seen in <a href="/wiki/Ashkenazi_Jews" title="Ashkenazi Jews">Ashkenazi Jews</a>.</p>
<p><a href="/wiki/Von_Willebrand_disease" title="Von Willebrand disease">Von Willebrand disease</a> (which behaves more like a platelet disorder except in severe cases), is the most common hereditary bleeding disorder and is characterized as being inherited autosomal recessive or dominant. In this disease, there is a defect in von Willebrand factor (vWF), which mediates the binding of glycoprotein Ib (GPIb) to collagen. This binding helps mediate the activation of platelets and formation of primary hemostasis.</p>
<p>Bernard-Soulier syndrome is a defect or deficiency in GPIb. GPIb, the receptor for vWF, can be defective and lead to lack of primary clot formation (primary hemostasis) and increased bleeding tendency. This is an autosomal recessive inherited disorder.</p>
<p>Thrombasthenia of Glanzman and Naegeli (<a href="/wiki/Glanzmann_thrombasthenia" title="Glanzmann thrombasthenia" class="mw-redirect">Glanzmann thrombasthenia</a>) is extremely rare. It is characterized by a defect in GPIIb/IIIa fibrinogen receptor complex. When GPIIb/IIIa receptor is dysfunctional, fibrinogen cannot cross-link platelets, which inhibits primary hemostasis. This is an autosomal recessive inherited disorder. In <a href="/wiki/Liver_failure" title="Liver failure">liver failure</a> (acute and chronic forms), there is insufficient production of coagulation factors by the liver; this may increase bleeding risk.</p>
<p>Deficiency of Vitamin K may also contribute to bleeding disorders because clotting factor maturation depends on Vitamin K.</p>
<p><a href="/wiki/Thrombosis" title="Thrombosis">Thrombosis</a> is the pathological development of blood clots. These clots may break free and become mobile, forming an <a href="/wiki/Embolism" title="Embolism">embolus</a> or grow to such a size that occludes the vessel in which it developed. An <a href="/wiki/Embolism" title="Embolism">embolism</a> is said to occur when the <a href="/wiki/Thrombus" title="Thrombus">thrombus</a> (blood clot) becomes a mobile embolus and migrates to another part of the body, interfering with blood circulation and hence impairing organ function downstream of the occlusion. This causes <a href="/wiki/Ischemia" title="Ischemia">ischemia</a> and often leasds to ischemic <a href="/wiki/Necrosis" title="Necrosis">necrosis</a> of tissue. Most cases of thrombosis are due to acquired extrinsic problems (<a href="/wiki/Surgery" title="Surgery">surgery</a>, <a href="/wiki/Cancer" title="Cancer">cancer</a>, <a href="/w/index.php?title=Immobility&amp;action=edit&amp;redlink=1" class="new" title="Immobility (page does not exist)">immobility</a>, <a href="/wiki/Obesity" title="Obesity">obesity</a>, <a href="/wiki/Economy_class_syndrome" title="Economy class syndrome" class="mw-redirect">economy class syndrome</a>), but a small proportion of people harbor predisposing conditions known collectively as thrombophilia (e.g., <a href="/wiki/Antiphospholipid_syndrome" title="Antiphospholipid syndrome">antiphospholipid syndrome</a>, <a href="/wiki/Factor_V_Leiden" title="Factor V Leiden">factor V Leiden</a>, and various other rarer genetic disorders).</p>
<p>Mutations in <a href="/wiki/Factor_XII" title="Factor XII">factor XII</a> have been associated with an asymptomatic prolongation in the clotting time and possibly a tendency toward <a href="/wiki/Thrombophlebitis" title="Thrombophlebitis">thrombophlebitis</a>. Other mutations have been linked with a rare form of <a href="/wiki/Angioedema" title="Angioedema">hereditary angioedema</a> (type III).</p>
<p><a name="Pharmacology" id="Pharmacology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=14" title="Edit section: Pharmacology">edit</a>]</span> <span class="mw-headline">Pharmacology</span></h2>
<p><a name="Procoagulants" id="Procoagulants"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=15" title="Edit section: Procoagulants">edit</a>]</span> <span class="mw-headline">Procoagulants</span></h3>
<p>The use of adsorbent chemicals, such as <a href="/wiki/Zeolite" title="Zeolite">zeolites</a>, and other <a href="/wiki/Hemostatic_agent" title="Hemostatic agent" class="mw-redirect">hemostatic agents</a> are also used for use in sealing severe injuries quickly (such as in traumatic bleeding secondary to gunshot wounds). Thrombin and fibrin <a href="/wiki/Glue" title="Glue" class="mw-redirect">glue</a> are used surgically to treat bleeding and to thrombose aneurysms.</p>
<p><a href="/wiki/Desmopressin" title="Desmopressin">Desmopressin</a> is used to improve platelet function by activating <a href="/wiki/Arginine_vasopressin_receptor_1A" title="Arginine vasopressin receptor 1A">arginine vasopressin receptor 1A</a>.</p>
<p>Coagulation factor concentrates are used to treat <a href="/wiki/Hemophilia" title="Hemophilia" class="mw-redirect">hemophilia</a>, to reverse the effects of anticoagulants, and to treat bleeding in patients with impaired coagulation factor synthesis or increased consumption. <a href="/wiki/Prothrombin_complex_concentrate" title="Prothrombin complex concentrate">Prothrombin complex concentrate</a>, <a href="/wiki/Cryoprecipitate" title="Cryoprecipitate">cryoprecipitate</a> and <a href="/wiki/Fresh_frozen_plasma" title="Fresh frozen plasma" class="mw-redirect">fresh frozen plasma</a> are commonly-used coagulation factor products. <a href="/wiki/Factor_VII" title="Factor VII">Recombinant activated human factor VII</a> is are increasingly popular in the treatment of major bleeding.</p>
<p><a href="/wiki/Tranexamic_acid" title="Tranexamic acid">Tranexamic acid</a> and <a href="/wiki/Aminocaproic_acid" title="Aminocaproic acid">aminocaproic acid</a> inhibit fibrinolysis, and lead to a <i>de facto</i> reduced bleeding rate. Before its withdrawal, <a href="/wiki/Aprotinin" title="Aprotinin">aprotinin</a> was used in some forms of major surgery to decrease bleeding risk and need for blood products.</p>
<p><a name="Anticoagulants" id="Anticoagulants"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=16" title="Edit section: Anticoagulants">edit</a>]</span> <span class="mw-headline">Anticoagulants</span></h3>
<div class="rellink noprint relarticle mainarticle">Main articles: <a href="/wiki/Antiplatelet_drug" title="Antiplatelet drug">Antiplatelet drug</a> and <a href="/wiki/Anticoagulant" title="Anticoagulant">Anticoagulant</a></div>
<p>Anticoagulants and anti-platelet agents are amongst the most commonly used medicines. <a href="/wiki/Antiplatelet_drug" title="Antiplatelet drug">Anti-platelet agents</a> include <a href="/wiki/Aspirin" title="Aspirin">aspirin</a>, <a href="/wiki/Clopidogrel" title="Clopidogrel">clopidogrel</a>, <a href="/wiki/Dipyridamole" title="Dipyridamole">dipyridamole</a> and <a href="/wiki/Ticlopidine" title="Ticlopidine">ticlopidine</a>; the parenteral <a href="/wiki/Glycoprotein_IIb/IIIa_inhibitors" title="Glycoprotein IIb/IIIa inhibitors">glycoprotein IIb/IIIa inhibitors</a> are used during <a href="/wiki/Angioplasty" title="Angioplasty">angioplasty</a>.</p>
<p>Of the anticoagulants, <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> (and related <a href="/wiki/Coumarin" title="Coumarin">coumarins</a>) and <a href="/wiki/Heparin" title="Heparin">heparin</a> are the most commonly used. Warfarin affects the vitamin K-dependent clotting factors (II, VII, IX,X) , whereas heparin and related compounds increase the action of antithrombin on thrombin and factor Xa. A newer class of drugs, the <a href="/wiki/Direct_thrombin_inhibitor" title="Direct thrombin inhibitor">direct thrombin inhibitors</a>, is under development; some members are already in clinical use (such as <a href="/wiki/Lepirudin" title="Lepirudin">lepirudin</a>). Also under development are other small molecular compounds that interfere directly with the enzymatic action of particular coagulation factors (e.g., <a href="/wiki/Rivaroxaban" title="Rivaroxaban">rivaroxaban</a>).</p>
<p><a name="Coagulation_factors" id="Coagulation_factors"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=17" title="Edit section: Coagulation factors">edit</a>]</span> <span class="mw-headline">Coagulation factors</span></h2>
<table class="wikitable">
<caption>Coagulation factors and related substances</caption>
<tr>
<th>Number and/or name</th>
<th>Function</th>
</tr>
<tr>
<td>I (<a href="/wiki/Fibrinogen" title="Fibrinogen" class="mw-redirect">fibrinogen</a>)</td>
<td>Forms clot (fibrin)</td>
</tr>
<tr>
<td>II (<a href="/wiki/Prothrombin" title="Prothrombin" class="mw-redirect">prothrombin</a>)</td>
<td>Its active form (IIa) activates I, V, VII, VIII, XI, XIII, protein C, platelets</td>
</tr>
<tr>
<td><a href="/wiki/Tissue_factor" title="Tissue factor">Tissue factor</a></td>
<td>Co-factor of VIIa (formerly known as factor III)</td>
</tr>
<tr>
<td><a href="/wiki/Calcium" title="Calcium">Calcium</a></td>
<td>Required for coagulation factors to bind to phospholipid (formerly known as factor IV)</td>
</tr>
<tr>
<td><a href="/wiki/Factor_V" title="Factor V">V</a> (proaccelerin, labile factor)</td>
<td>Co-factor of X with which it forms the <a href="/wiki/Prothrombinase" title="Prothrombinase">prothrombinase</a> complex</td>
</tr>
<tr>
<td>VI</td>
<td><i>Unassigned</i> – old name of Factor Va</td>
</tr>
<tr>
<td><a href="/wiki/Factor_VII" title="Factor VII">VII</a> (stable factor)</td>
<td>Activates IX, X</td>
</tr>
<tr>
<td><a href="/wiki/Factor_VIII" title="Factor VIII">VIII</a> (antihemophilic factor)</td>
<td>Co-factor of IX with which it forms the <a href="/wiki/Tenase" title="Tenase">tenase</a> complex</td>
</tr>
<tr>
<td><a href="/wiki/Factor_IX" title="Factor IX">IX</a> (Christmas factor)</td>
<td>Activates X: forms <a href="/wiki/Tenase" title="Tenase">tenase</a> complex with factor VIII</td>
</tr>
<tr>
<td><a href="/wiki/Factor_X" title="Factor X">X</a> (Stuart-Prower factor)</td>
<td>Activates II: forms <a href="/wiki/Prothrombinase" title="Prothrombinase">prothrombinase</a> complex with factor V</td>
</tr>
<tr>
<td><a href="/wiki/Factor_XI" title="Factor XI">XI</a> (plasma thromboplastin antecedent)</td>
<td>Activates IX</td>
</tr>
<tr>
<td><a href="/wiki/Factor_XII" title="Factor XII">XII</a> (Hageman factor)</td>
<td>Activates factor XI and prekallikrein</td>
</tr>
<tr>
<td><a href="/wiki/Factor_XIII" title="Factor XIII">XIII</a> (fibrin-stabilizing factor)</td>
<td>Crosslinks fibrin</td>
</tr>
<tr>
<td><a href="/wiki/Von_Willebrand_factor" title="Von Willebrand factor">von Willebrand factor</a></td>
<td>Binds to VIII, mediates platelet adhesion</td>
</tr>
<tr>
<td><a href="/wiki/Prekallikrein" title="Prekallikrein">prekallikrein</a></td>
<td>Activates XII and prekallikrein; cleaves HMWK</td>
</tr>
<tr>
<td><a href="/wiki/High-molecular-weight_kininogen" title="High-molecular-weight kininogen">high-molecular-weight kininogen</a> (HMWK)</td>
<td>Supports reciprocal activation of XII, XI, and prekallikrein</td>
</tr>
<tr>
<td><a href="/wiki/Fibronectin" title="Fibronectin">fibronectin</a></td>
<td>Mediates cell adhesion</td>
</tr>
<tr>
<td><a href="/wiki/Antithrombin" title="Antithrombin">antithrombin</a> III</td>
<td>Inhibits IIa, Xa, and other proteases;</td>
</tr>
<tr>
<td><a href="/wiki/Heparin_cofactor_II" title="Heparin cofactor II">heparin cofactor II</a></td>
<td>Inhibits IIa, cofactor for heparin and <a href="/wiki/Dermatan_sulfate" title="Dermatan sulfate">dermatan sulfate</a> ("minor antithrombin")</td>
</tr>
<tr>
<td><a href="/wiki/Protein_C" title="Protein C">protein C</a></td>
<td>Inactivates Va and VIIIa</td>
</tr>
<tr>
<td><a href="/wiki/Protein_S" title="Protein S">protein S</a></td>
<td>Cofactor for activated protein C (APC, inactive when bound to C4b-binding protein)</td>
</tr>
<tr>
<td><a href="/wiki/Protein_Z" title="Protein Z">protein Z</a></td>
<td>Mediates thrombin adhesion to phospholipids and stimulates degradation of factor X by ZPI</td>
</tr>
<tr>
<td><a href="/wiki/Protein_Z-related_protease_inhibitor" title="Protein Z-related protease inhibitor">Protein Z-related protease inhibitor</a> (ZPI)</td>
<td>Degrades factors X (in presence of protein Z) and XI (independently)</td>
</tr>
<tr>
<td><a href="/wiki/Plasminogen" title="Plasminogen" class="mw-redirect">plasminogen</a></td>
<td>Converts to plasmin, lyses fibrin and other proteins</td>
</tr>
<tr>
<td><a href="/wiki/Alpha_2-antiplasmin" title="Alpha 2-antiplasmin">alpha 2-antiplasmin</a></td>
<td>Inhibits plasmin</td>
</tr>
<tr>
<td><a href="/wiki/Tissue_plasminogen_activator" title="Tissue plasminogen activator">tissue plasminogen activator</a> (tPA)</td>
<td>Activates plasminogen</td>
</tr>
<tr>
<td><a href="/wiki/Urokinase" title="Urokinase">urokinase</a></td>
<td>Activates plasminogen</td>
</tr>
<tr>
<td><a href="/wiki/Plasminogen_activator_inhibitor-1" title="Plasminogen activator inhibitor-1">plasminogen activator inhibitor-1</a> (PAI1)</td>
<td>Inactivates tPA &amp; urokinase (endothelial PAI)</td>
</tr>
<tr>
<td><a href="/wiki/Plasminogen_activator_inhibitor-2" title="Plasminogen activator inhibitor-2">plasminogen activator inhibitor-2</a> (PAI2)</td>
<td>Inactivates tPA &amp; urokinase (<a href="/wiki/Placenta" title="Placenta">placental</a> PAI)</td>
</tr>
<tr>
<td><a href="/wiki/Cancer_procoagulant" title="Cancer procoagulant">cancer procoagulant</a></td>
<td>Pathological <a href="/wiki/Factor_X" title="Factor X">factor X</a> activator linked to thrombosis in <a href="/wiki/Cancer" title="Cancer">cancer</a></td>
</tr>
</table>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=18" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p><a name="Initial_discoveries" id="Initial_discoveries"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=19" title="Edit section: Initial discoveries">edit</a>]</span> <span class="mw-headline">Initial discoveries</span></h3>
<p>Theories on the coagulation of blood have existed since antiquity. Physiologist <a href="/wiki/Johannes_Peter_M%C3%BCller" title="Johannes Peter Müller">Johannes Müller</a> (1801-1858) described fibrin, the substance of a thrombus. Its soluble precursor, fibrinogen, was thus named by <a href="/wiki/Rudolf_Virchow" title="Rudolf Virchow">Rudolf Virchow</a> (1821-1902), and isolated chemically by <a href="/w/index.php?title=Prosper_Sylvain_Denis&amp;action=edit&amp;redlink=1" class="new" title="Prosper Sylvain Denis (page does not exist)">Prosper Sylvain Denis</a> (1799-1863). <a href="/wiki/Alexander_Schmidt_(physiologist)" title="Alexander Schmidt (physiologist)">Alexander Schmidt</a> suggested that the conversion from fibrinogen to fibrin is the result of an <a href="/wiki/Enzyme" title="Enzyme">enzymatic</a> process, and labeled the hypothetical enzyme "thrombin" and its precursor "prothrombin".<sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup> <a href="/wiki/Nicolas_Maurice_Arthus" title="Nicolas Maurice Arthus">Arthus</a> discovered in 1890 that calcium was essential in coagulation.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Shapiro_4-0" class="reference"><a href="#cite_note-Shapiro-4" title=""><span>[</span>5<span>]</span></a></sup> <a href="/wiki/Platelet" title="Platelet">Platelets</a> were identified in 1865, and their function was elucidated by <a href="/wiki/Giulio_Bizzozero" title="Giulio Bizzozero">Giulio Bizzozero</a> in 1882.<sup id="cite_ref-Brewer_5-0" class="reference"><a href="#cite_note-Brewer-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p>The theory that thrombin is generated by the presence of <a href="/wiki/Tissue_factor" title="Tissue factor">tissue factor</a> was consolidated by <a href="/wiki/Paul_Morawitz" title="Paul Morawitz">Paul Morawitz</a> in 1905.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup> At this stage, it was known that <i>thrombokinase/thromboplastin</i> (factor III) is released by damaged tissues, reacting with <i>prothrombin</i> (II), which, together with <a href="/wiki/Calcium_in_biology" title="Calcium in biology">calcium</a> (IV), forms <i>thrombin</i>, which converts fibrinogen into <i>fibrin</i> (I).<sup id="cite_ref-Giangrande_7-0" class="reference"><a href="#cite_note-Giangrande-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p><a name="Coagulation_factors_2" id="Coagulation_factors_2"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=20" title="Edit section: Coagulation factors">edit</a>]</span> <span class="mw-headline">Coagulation factors</span></h3>
<p>The remainder of the biochemical factors in the process of coagulation were largely discovered in the 20th century.</p>
<p>A first clue as to the actual complexity of the system of coagulation was the discovery of <i>proaccelerin</i> (initially and later called Factor V) by Paul Owren (1905-1990) in 1947. He also postulated its function to be the generation of accelerin (Factor VI), which later turned out to be the activated form of V (or Va); hence, VI is not now in active use.<sup id="cite_ref-Giangrande_7-1" class="reference"><a href="#cite_note-Giangrande-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p>Factor VII (also known as <i>serum prothrombin conversion accelerator</i> or <i>proconvertin</i>, precipitated by barium sulfate) was discovered in a young female patient in 1949 and 1951 by different groups.</p>
<p><a href="/wiki/Factor_VIII" title="Factor VIII">Factor VIII</a> turned out to be deficient in the clinically recognised but etiologically elusive <a href="/wiki/Haemophilia_A" title="Haemophilia A">hemophilia A</a>; it was identified in the 1950s and is alternatively called <i>antihemophilic globulin</i> due to its capability to correct hemophilia A.<sup id="cite_ref-Giangrande_7-2" class="reference"><a href="#cite_note-Giangrande-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p>Factor IX was discovered in 1952 in a young patient with <a href="/wiki/Haemophilia_B" title="Haemophilia B">hemophilia B</a> named <a href="/wiki/Stephen_Christmas" title="Stephen Christmas">Stephen Christmas</a> (1947-1993). His deficiency was described by Dr. Rosemary Biggs and Professor <a href="/wiki/R.G._MacFarlane" title="R.G. MacFarlane" class="mw-redirect">R.G. MacFarlane</a> in Oxford, UK. The factor is, hence, called Christmas Factor or Christmas Eve Factor. Christmas lived in Canada, and campaigned for blood transfusion safety until succumbing to transfusion-related <a href="/wiki/AIDS" title="AIDS">AIDS</a> at age 46. An alternative name for the factor is <i>plasma thromboplastin component</i>, given by an independent group in California.<sup id="cite_ref-Giangrande_7-3" class="reference"><a href="#cite_note-Giangrande-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p>Hageman factor, now known as factor XII, was identified in 1955 in an asymptomatic patient with a prolonged bleeding time named of John Hageman. Factor X, or Stuart-Prower factor, followed, in 1956. This protein was identified in a Ms. Audrey Prower of London, who had a lifelong bleeding tendency. In 1957, an American group identified the same factor in a Mr. Rufus Stuart. Factors XI and XIII were identified in 1953 and 1961, respectively.<sup id="cite_ref-Giangrande_7-4" class="reference"><a href="#cite_note-Giangrande-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p>The view that the coagulation process is a "cascade" or "waterfall" was enunciated almost simultaneously by MacFarlane<sup id="cite_ref-pmid14167839_8-0" class="reference"><a href="#cite_note-pmid14167839-8" title=""><span>[</span>9<span>]</span></a></sup> in the UK and by Davie and Ratnoff<sup id="cite_ref-pmid14173416_9-0" class="reference"><a href="#cite_note-pmid14173416-9" title=""><span>[</span>10<span>]</span></a></sup> in the USA, respectively.</p>
<p><a name="Nomenclature" id="Nomenclature"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=21" title="Edit section: Nomenclature">edit</a>]</span> <span class="mw-headline">Nomenclature</span></h3>
<p>The usage of <a href="/wiki/Roman_numeral" title="Roman numeral" class="mw-redirect">Roman numerals</a> rather than eponyms or systematic names was agreed upon during annual conferences (starting in 1955) of hemostasis experts. In 1962, consensus was achieved on the numbering of factors I-XII.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup> This committee evolved into the present-day International Committee on Thrombosis and Hemostasis (ICTH). Assignment of numerals ceased in 1963 after the naming of Factor XIII. The names Fletcher Factor and Fitzgerald Factor were given to further coagulation-related proteins, namely <a href="/wiki/Prekallikrein" title="Prekallikrein">prekallikrein</a> and <a href="/wiki/High-molecular-weight_kininogen" title="High-molecular-weight kininogen">high-molecular-weight kininogen</a>, respectively.<sup id="cite_ref-Giangrande_7-5" class="reference"><a href="#cite_note-Giangrande-7" title=""><span>[</span>8<span>]</span></a></sup></p>
<p>Factors III and VI are unassigned, as thromboplastin was never identified, and actually turned out to consist of ten further factors, and accelerin was found to be activated Factor V.</p>
<p><a name="Other_species" id="Other_species"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=22" title="Edit section: Other species">edit</a>]</span> <span class="mw-headline">Other species</span></h2>
<p>All mammals have an extremely closely related blood coagulation process, using a combined cellular and serine protease process. In fact, it is possible for any mammalian coagulation factor to "cleave" its equivalent target in any other mammal. The only nonmammalian animal known to use serine proteases for blood coagulation is the <a href="/wiki/Horseshoe_crab" title="Horseshoe crab">horseshoe crab</a>.</p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=23" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-Furie-0"><b><a href="#cite_ref-Furie_0-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFurie_B.2C_Furie_BC2005">Furie B, Furie BC (2005). "<a href="http://www.jci.org/cgi/content/full/115/12/3355" class="external text" title="http://www.jci.org/cgi/content/full/115/12/3355" rel="nofollow">Thrombus formation in vivo</a>". <i>J. Clin. Invest.</i> <b>115</b> (12): 3355–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1172%2FJCI26987" class="external text" title="http://dx.doi.org/10.1172%2FJCI26987" rel="nofollow">10.1172/JCI26987</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16322780" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16322780">PMID 16322780</a><span class="printonly">. <a href="http://www.jci.org/cgi/content/full/115/12/3355" class="external free" title="http://www.jci.org/cgi/content/full/115/12/3355" rel="nofollow">http://www.jci.org/cgi/content/full/115/12/3355</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Thrombus+formation+in+vivo&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.aulast=Furie+B%2C+Furie+BC&amp;rft.au=Furie+B%2C+Furie+BC&amp;rft.date=2005&amp;rft.volume=115&amp;rft.issue=12&amp;rft.pages=3355%E2%80%9362&amp;rft_id=info:doi/10.1172%2FJCI26987&amp;rft_id=info:pmid/16322780&amp;rft_id=http%3A%2F%2Fwww.jci.org%2Fcgi%2Fcontent%2Ffull%2F115%2F12%2F3355&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span> Full text at <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1297262" class="external text" title="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1297262" rel="nofollow">1297262</a></li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSchmidt_A1872">Schmidt A (1872). "Neue Untersuchungen ueber die Fasserstoffesgerinnung". <i>Pflüger's Archiv für die gesamte Physiologie</i> <b>6</b>: 413–538. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2FBF01612263" class="external text" title="http://dx.doi.org/10.1007%2FBF01612263" rel="nofollow">10.1007/BF01612263</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Neue+Untersuchungen+ueber+die+Fasserstoffesgerinnung&amp;rft.jtitle=Pfl%C3%BCger%27s+Archiv+f%C3%BCr+die+gesamte+Physiologie&amp;rft.aulast=Schmidt+A&amp;rft.au=Schmidt+A&amp;rft.date=1872&amp;rft.volume=6&amp;rft.pages=413%E2%80%93538&amp;rft_id=info:doi/10.1007%2FBF01612263&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> Schmidt A. Zur Blutlehre. Leipzig: Vogel, 1892.</li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFArthus_M.2C_Pag.C3.A8s_C1890">Arthus M, Pagès C (1890). "Nouvelle theorie chimique de la coagulation du sang". <i>Arch Physiol Norm Pathol</i> <b>5</b>: 739–46.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Nouvelle+theorie+chimique+de+la+coagulation+du+sang&amp;rft.jtitle=Arch+Physiol+Norm+Pathol&amp;rft.aulast=Arthus+M%2C+Pag%C3%A8s+C&amp;rft.au=Arthus+M%2C+Pag%C3%A8s+C&amp;rft.date=1890&amp;rft.volume=5&amp;rft.pages=739%E2%80%9346&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Shapiro-4"><b><a href="#cite_ref-Shapiro_4-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFShapiro_SS2003">Shapiro SS (2003). "Treating thrombosis in the 21st century". <i>N. Engl. J. Med.</i> <b>349</b> (18): 1762–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMe038152" class="external text" title="http://dx.doi.org/10.1056%2FNEJMe038152" rel="nofollow">10.1056/NEJMe038152</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14585945" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14585945">PMID 14585945</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treating+thrombosis+in+the+21st+century&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Shapiro+SS&amp;rft.au=Shapiro+SS&amp;rft.date=2003&amp;rft.volume=349&amp;rft.issue=18&amp;rft.pages=1762%E2%80%934&amp;rft_id=info:doi/10.1056%2FNEJMe038152&amp;rft_id=info:pmid/14585945&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Brewer-5"><b><a href="#cite_ref-Brewer_5-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBrewer_DB2006">Brewer DB (2006). "Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet". <i>Br. J. Haematol.</i> <b>133</b> (3): 251–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1365-2141.2006.06036.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1365-2141.2006.06036.x" rel="nofollow">10.1111/j.1365-2141.2006.06036.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16643426" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16643426">PMID 16643426</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Max+Schultze+%281865%29%2C+G.+Bizzozero+%281882%29+and+the+discovery+of+the+platelet&amp;rft.jtitle=Br.+J.+Haematol.&amp;rft.aulast=Brewer+DB&amp;rft.au=Brewer+DB&amp;rft.date=2006&amp;rft.volume=133&amp;rft.issue=3&amp;rft.pages=251%E2%80%938&amp;rft_id=info:doi/10.1111%2Fj.1365-2141.2006.06036.x&amp;rft_id=info:pmid/16643426&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMorawitz_P1905">Morawitz P (1905). "Die Chemie der Blutgerinnung". <i>Ergebn Physiol</i> <b>4</b>: 307–422.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Die+Chemie+der+Blutgerinnung&amp;rft.jtitle=Ergebn+Physiol&amp;rft.aulast=Morawitz+P&amp;rft.au=Morawitz+P&amp;rft.date=1905&amp;rft.volume=4&amp;rft.pages=307%E2%80%93422&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Giangrande-7">^ <a href="#cite_ref-Giangrande_7-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Giangrande_7-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Giangrande_7-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Giangrande_7-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Giangrande_7-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Giangrande_7-5" title=""><sup><i><b>f</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFGiangrande_PL2003">Giangrande PL (2003). "Six characters in search of an author: the history of the nomenclature of coagulation factors". <i>Br. J. Haematol.</i> <b>121</b> (5): 703–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1365-2141.2003.04333.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1365-2141.2003.04333.x" rel="nofollow">10.1046/j.1365-2141.2003.04333.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12780784" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12780784">PMID 12780784</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Six+characters+in+search+of+an+author%3A+the+history+of+the+nomenclature+of+coagulation+factors&amp;rft.jtitle=Br.+J.+Haematol.&amp;rft.aulast=Giangrande+PL&amp;rft.au=Giangrande+PL&amp;rft.date=2003&amp;rft.volume=121&amp;rft.issue=5&amp;rft.pages=703%E2%80%9312&amp;rft_id=info:doi/10.1046%2Fj.1365-2141.2003.04333.x&amp;rft_id=info:pmid/12780784&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14167839-8"><b><a href="#cite_ref-pmid14167839_8-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMacFarlane_RG1964">MacFarlane RG (1964). "An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier". <i>Nature</i> <b>202</b>: 498–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1038%2F202498a0" class="external text" title="http://dx.doi.org/10.1038%2F202498a0" rel="nofollow">10.1038/202498a0</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14167839" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14167839">PMID 14167839</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=An+enzyme+cascade+in+the+blood+clotting+mechanism%2C+and+its+function+as+a+biochemical+amplifier&amp;rft.jtitle=Nature&amp;rft.aulast=MacFarlane+RG&amp;rft.au=MacFarlane+RG&amp;rft.date=1964&amp;rft.volume=202&amp;rft.pages=498%E2%80%939&amp;rft_id=info:doi/10.1038%2F202498a0&amp;rft_id=info:pmid/14167839&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14173416-9"><b><a href="#cite_ref-pmid14173416_9-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDavie_EW.2C_Ratnoff_OD1964">Davie EW, Ratnoff OD (1964). "Waterfall sequence for intrinsic blood clotting". <i>Science</i> <b>145</b>: 1310–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1126%2Fscience.145.3638.1310" class="external text" title="http://dx.doi.org/10.1126%2Fscience.145.3638.1310" rel="nofollow">10.1126/science.145.3638.1310</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14173416" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14173416">PMID 14173416</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Waterfall+sequence+for+intrinsic+blood+clotting&amp;rft.jtitle=Science&amp;rft.aulast=Davie+EW%2C+Ratnoff+OD&amp;rft.au=Davie+EW%2C+Ratnoff+OD&amp;rft.date=1964&amp;rft.volume=145&amp;rft.pages=1310%E2%80%932&amp;rft_id=info:doi/10.1126%2Fscience.145.3638.1310&amp;rft_id=info:pmid/14173416&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWright_IS1962">Wright IS (1962). "The nomenclature of blood clotting factors". <i>Can Med Assoc J</i> <b>86</b>: 373–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14008442" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14008442">PMID 14008442</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+nomenclature+of+blood+clotting+factors&amp;rft.jtitle=Can+Med+Assoc+J&amp;rft.aulast=Wright+IS&amp;rft.au=Wright+IS&amp;rft.date=1962&amp;rft.volume=86&amp;rft.pages=373%E2%80%934&amp;rft_id=info:pmid/14008442&amp;rfr_id=info:sid/en.wikipedia.org:Coagulation"><span style="display: none;">&#160;</span></span> Full text at <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1848865" class="external text" title="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1848865" rel="nofollow">1848865</a></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=24" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<p><a name="3D_structures" id="3D_structures"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Coagulation&amp;action=edit&amp;section=25" title="Edit section: 3D structures">edit</a>]</span> <span class="mw-headline">3D structures</span></h3>
<ul>
<li><a href="/wiki/Orientations_of_Proteins_in_Membranes_database" title="Orientations of Proteins in Membranes database">UMich Orientation of Proteins in Membranes</a> <i><a href="http://opm.phar.umich.edu/families.php?superfamily=97" class="external text" title="http://opm.phar.umich.edu/families.php?superfamily=97" rel="nofollow">families/superfamily-97</a></i> - Calculated orientations of complexes with <a href="/wiki/GLA_domain" title="GLA domain" class="mw-redirect">GLA domains</a> in membrane</li>
<li><a href="/wiki/Orientations_of_Proteins_in_Membranes_database" title="Orientations of Proteins in Membranes database">UMich Orientation of Proteins in Membranes</a> <i><a href="http://opm.phar.umich.edu/families.php?superfamily=48" class="external text" title="http://opm.phar.umich.edu/families.php?superfamily=48" rel="nofollow">families/superfamily-48</a></i> - <a href="/wiki/Discoidin_domain" title="Discoidin domain">Discoidin domains</a> of blood coagulation factors</li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:#e7dcc3" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:#e7dcc3;border:none;; font-size:xx-small;"><a href="/wiki/Template:Coagulation" title="Template:Coagulation"><span title="View this template" style=";background:#e7dcc3;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Coagulation&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Coagulation (page does not exist)"><span title="Discussion about this template" style=";background:#e7dcc3;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Coagulation&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Coagulation&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:#e7dcc3;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Protein" title="Protein">Proteins</a>: <strong class="selflink">coagulation</strong></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: AntiqueWhite;">Coagulation&#160;factors</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: AntiqueWhite;">
<div style="padding:0em 0.75em;"><a href="/wiki/Contact_activation_pathway#Platelet_activation" title="Contact activation pathway" class="mw-redirect">Primary hemostasis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Von_Willebrand_factor" title="Von Willebrand factor">vWF</a><br />
<i><a href="/wiki/Platelet_membrane_glycoprotein" title="Platelet membrane glycoprotein">platelet membrane glycoproteins</a>:</i> <a href="/wiki/Glycoprotein_Ib" title="Glycoprotein Ib">Ib</a> (<a href="/wiki/GP1BA" title="GP1BA">A</a>, <a href="/wiki/GP1BB" title="GP1BB">B</a>, <a href="/wiki/Glycoprotein_IX" title="Glycoprotein IX">IX</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Glycoprotein_IIb/IIIa" title="Glycoprotein IIb/IIIa">IIb/IIIa</a> (<a href="/wiki/ITGA2B" title="ITGA2B">IIb</a>, <a href="/wiki/CD61" title="CD61">IIIa</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/GPVI" title="GPVI">VI</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: AntiqueWhite;">
<div style="padding:0em 0.75em;"><a href="/wiki/Contact_activation_pathway#Contact_activation_pathway_.28intrinsic.29" title="Contact activation pathway" class="mw-redirect">Intrinsic pathway</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/High-molecular_weight_kininogen" title="High-molecular weight kininogen" class="mw-redirect">HMWK</a>/<a href="/wiki/Bradykinin" title="Bradykinin">Bradykinin</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Prekallikrein" title="Prekallikrein">Prekallikrein</a>/<a href="/wiki/Kallikrein" title="Kallikrein">Kallikrein</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Factor_XII" title="Factor XII">XII "Hageman"</a><br />
<a href="/wiki/Factor_XI" title="Factor XI">XI</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Factor_IX" title="Factor IX">IX</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Factor_VIII" title="Factor VIII">VIII</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: AntiqueWhite;">
<div style="padding:0em 0.75em;"><a href="/wiki/Contact_activation_pathway#Tissue_factor_pathway_.28extrinsic.29" title="Contact activation pathway" class="mw-redirect">Extrinsic pathway</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Tissue_factor" title="Tissue factor">III "Tissue factor"</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Factor_VII" title="Factor VII">VII</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: AntiqueWhite;">
<div style="padding:0em 0.75em;"><a href="/wiki/Contact_activation_pathway#Final_common_pathway" title="Contact activation pathway" class="mw-redirect">Common pathway</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Factor_X" title="Factor X">X</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Factor_V" title="Factor V">V</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Thrombin" title="Thrombin">II "(Pro)thrombin"</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Fibrin" title="Fibrin">I "Fibrin"</a><br />
<a href="/wiki/Factor_XIII" title="Factor XIII">XIII</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: AntiqueWhite;"><a href="/wiki/Coagulation_inhibitor" title="Coagulation inhibitor" class="mw-redirect">Coagulation inhibitors</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Antithrombin" title="Antithrombin">Antithrombin (inhibits II, IX, X, XI, XII)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Protein_C" title="Protein C">Protein&#160;C (inhibits V, VIII)</a>/<a href="/wiki/Protein_S" title="Protein S">Protein&#160;S (cofactor for protein C)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Protein_Z" title="Protein Z">Protein&#160;Z (inhibits X)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Protein_Z-related_protease_inhibitor" title="Protein Z-related protease inhibitor">ZPI (inhibits X, XI)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tissue_factor_pathway_inhibitor" title="Tissue factor pathway inhibitor">TFPI (inhibits III)</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: AntiqueWhite;"><a href="/wiki/Thrombolysis" title="Thrombolysis">Thrombolysis</a>/<a href="/wiki/Fibrinolysis" title="Fibrinolysis">fibrinolysis</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Plasmin" title="Plasmin">Plasmin</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tissue_plasminogen_activator" title="Tissue plasminogen activator">tPA</a>/<a href="/wiki/Urokinase" title="Urokinase">urokinase</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Plasminogen_activator_inhibitor-1" title="Plasminogen activator inhibitor-1">PAI-1</a>/<a href="/wiki/Plasminogen_activator_inhibitor-2" title="Plasminogen activator inhibitor-2">2</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Alpha_2-antiplasmin" title="Alpha 2-antiplasmin">α2-AP</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Alpha_2-macroglobulin" title="Alpha 2-macroglobulin" class="mw-redirect">α2-macroglobulin</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Thrombin-activatable_fibrinolysis_inhibitor" title="Thrombin-activatable fibrinolysis inhibitor">TAFI</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:#efefef" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:#efefef;border:none;; font-size:xx-small;"><a href="/wiki/Template:Blood_physiology" title="Template:Blood physiology"><span title="View this template" style=";background:#efefef;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Blood_physiology&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Blood physiology (page does not exist)"><span title="Discussion about this template" style=";background:#efefef;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Blood_physiology&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Blood_physiology&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:#efefef;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;">Blood <a href="/wiki/Human_physiology" title="Human physiology">physiology</a></span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Haematopoiesis" title="Haematopoiesis">Haematopoiesis</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Lymphopoiesis" title="Lymphopoiesis">Lymphopoiesis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Lymphoblast" title="Lymphoblast">Lymphoblast</a>, <a href="/wiki/Prolymphocyte" title="Prolymphocyte">Prolymphocyte</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Myelopoiesis" title="Myelopoiesis">Myelopoiesis</a><br />
(<a href="/wiki/CFU-GEMM" title="CFU-GEMM">CFU-GEMM</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/CFU-GM" title="CFU-GM">CFU-GM</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Granulopoiesis" title="Granulopoiesis">Granulopoiesis</a> (<a href="/wiki/Myeloblast" title="Myeloblast">Myeloblast</a>, <a href="/wiki/Promyelocyte" title="Promyelocyte">Promyelocyte</a>, <a href="/wiki/Myelocyte" title="Myelocyte">Myelocyte</a>, <a href="/wiki/Metamyelocyte" title="Metamyelocyte">Metamyelocyte</a>, <a href="/wiki/Band_cell" title="Band cell">Band cell</a>)<br />
<a href="/wiki/Monocytopoiesis" title="Monocytopoiesis">Monocytopoiesis</a> (<a href="/wiki/Monoblast" title="Monoblast">Monoblast</a>, <a href="/wiki/Promonocyte" title="Promonocyte">Promonocyte</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Megakaryocyte-erythroid_progenitor_cell" title="Megakaryocyte-erythroid progenitor cell">MEP</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Thrombopoiesis" title="Thrombopoiesis">Thrombopoiesis</a> (<a href="/wiki/Megakaryoblast" title="Megakaryoblast">Megakaryoblast</a>, <a href="/wiki/Promegakaryocyte" title="Promegakaryocyte">Promegakaryocyte</a>)<br />
<a href="/wiki/Erythropoiesis" title="Erythropoiesis">Erythropoiesis</a> (<a href="/wiki/Proerythroblast" title="Proerythroblast">Proerythroblast</a>, <a href="/wiki/Normoblast" title="Normoblast">Normoblast</a>, <a href="/wiki/Reticulocyte" title="Reticulocyte">Reticulocyte</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:MistyRose;;">
<div style="padding:0em 0.75em;">General</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Extramedullary_hematopoiesis" title="Extramedullary hematopoiesis">Extramedullary hematopoiesis</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:MistyRose;;"><a href="/wiki/Hemostasis" title="Hemostasis">Hemostasis</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><strong class="selflink">Coagulation</strong> (<a href="/wiki/Fibrinolysis" title="Fibrinolysis">Fibrinolysis</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Clot_retraction" title="Clot retraction">Clot retraction</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Platelet_adhesiveness" title="Platelet adhesiveness">Platelet adhesiveness</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 7131/1000000
Post-expand include size: 91064/2048000 bytes
Template argument size: 45146/2048000 bytes
Expensive parser function count: 0/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:212193-0!1!0!default!!en!2 and timestamp 20090404223450 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Coagulation">http://en.wikipedia.org/wiki/Coagulation</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Hematology" title="Category:Hematology">Hematology</a></span> | <span dir='ltr'><a href="/wiki/Category:Coagulation_system" title="Category:Coagulation system">Coagulation system</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Coagulation" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Coagulation" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Coagulation&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Coagulation&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Coagulation" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Coagulation" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Coagulation" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Coagulation&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Coagulation&amp;oldid=281786867" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Coagulation&amp;id=281786867">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ang"><a href="http://ang.wikipedia.org/wiki/%C8%9Cerinnung">Anglo-Saxon</a></li>
				<li class="interwiki-az"><a href="http://az.wikipedia.org/wiki/Qan%C4%B1n_laxtalanmas%C4%B1">Azərbaycan</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Sr%C3%A1%C5%BEen%C3%AD_krve">Česky</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Koagulation">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/H%C3%A4mostase#.C3.9Cbersicht_.C3.BCber_Gerinnungsfaktoren_und_Inhibitoren">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Coagulaci%C3%B3n">Español</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D9%84%D8%AE%D8%AA%D9%87">فارسی</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Coagulation_sanguine">Français</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Coagulazione_del_sangue">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%A7%D7%A8%D7%99%D7%A9%D7%AA_%D7%93%D7%9D">עברית</a></li>
				<li class="interwiki-lt"><a href="http://lt.wikipedia.org/wiki/Kraujo_kre%C5%A1%C4%97jimas">Lietuvių</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Bloedstolling">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E5%87%9D%E5%9B%BA%E3%83%BB%E7%B7%9A%E6%BA%B6%E7%B3%BB">日本語</a></li>
				<li class="interwiki-om"><a href="http://om.wikipedia.org/wiki/Coagulation">Oromoo</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Krzepni%C4%99cie_krwi">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Coagula%C3%A7%C3%A3o_sangu%C3%ADnea">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%9A%D0%BE%D0%B0%D0%B3%D1%83%D0%BB%D1%8F%D1%86%D0%B8%D1%8F_(%D0%B3%D0%B5%D0%BC%D0%B0%D1%82%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F)">Русский</a></li>
				<li class="interwiki-simple"><a href="http://simple.wikipedia.org/wiki/Clot">Simple English</a></li>
				<li class="interwiki-sl"><a href="http://sl.wikipedia.org/wiki/Strjevanje_krvi">Slovenščina</a></li>
				<li class="interwiki-sr"><a href="http://sr.wikipedia.org/wiki/%D0%97%D0%B3%D1%80%D1%83%D1%88%D0%B0%D0%B2%D0%B0%D1%9A%D0%B5_%D0%BA%D1%80%D0%B2%D0%B8">Српски / Srpski</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Veren_hyytyminen">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Blodkoagulering">Svenska</a></li>
				<li class="interwiki-ta"><a href="http://ta.wikipedia.org/wiki/%E0%AE%87%E0%AE%B0%E0%AE%A4%E0%AF%8D%E0%AE%A4_%E0%AE%89%E0%AE%B1%E0%AF%88%E0%AE%A4%E0%AE%B2%E0%AF%8D">தமிழ்</a></li>
				<li class="interwiki-vi"><a href="http://vi.wikipedia.org/wiki/S%E1%BB%B1_%C4%91%C3%B4ng_m%C3%A1u">Tiếng Việt</a></li>
				<li class="interwiki-yi"><a href="http://yi.wikipedia.org/wiki/%D7%91%D7%9C%D7%95%D7%98_%D7%A7%D7%9C%D7%90%D7%98%D7%99%D7%A0%D7%92">ייִדיש</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E5%87%9D%E8%A1%80%E5%9B%A0%E5%AD%90">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 4 April 2009, at 22:34.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv149 in 1.568 secs. --></body></html>
